Partner With Us NRI

Lincoln Pharmaceuticals Ltd share Price Today

Company details

6M Return 77.54%
1Y Return 100.67%
Mkt Cap.(Cr) 1,357.73
Volume 100,662
Div Yield 0.22%
OI Chg %
Volume 100,662

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Lincoln Pharmaceuticals Ltd Stocks COMPARISION


Equity Capital: 502.47 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 15,779.50 22,156.90
LAST 3M 54,802.13 -2,099.03
LAST 6M 93,089.45 78,838.27
LAST 12M 161,092.98 118,023.38

Lincoln Pharmaceuticals Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. `95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.`96 to part-finance its project. The Company launched Next Generation Progesterone Therapy "ProlinSpray" during the year 2018. During the year 2021-22, Lincoln Parenteral Limited (Transferor Company), an erstwhile subsidiary, merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this, the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.

Registered Address

Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060

Tel : 91-079-67778000
Email : info:lincolnpharma.com
Website : http://www.lincolnpharma.com

Sharepro Services India Pvt Lt

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531633
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE405C01035

FAQ’s on Lincoln Pharmaceuticals Ltd Shares

You can buy Lincoln Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lincoln Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Dec 01, 2023 03:55 PM the closing price of Lincoln Pharmaceuticals Ltd was ₹ 677.85.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Dec 01, 2023 03:55 PM, the market cap of Lincoln Pharmaceuticals Ltd stood at ₹ 1,357.73.

The latest PE ratio of Lincoln Pharmaceuticals Ltd as of Dec 01, 2023 03:55 PM is 16.81

The latest PB ratio of Lincoln Pharmaceuticals Ltd as of Dec 01, 2023 03:55 PM is 0.40

The 52-week high of Lincoln Pharmaceuticals Ltd is ₹ 692.00 while the 52-week low is ₹ 300.00

Download Our App

market app
market app